These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 37743493)

  • 21. Notch1 regulates invasion and metastasis of head and neck squamous cell carcinoma by inducing EMT through c-Myc.
    Inamura N; Kimura T; Wang L; Yanagi H; Tsuda M; Tanino M; Nishihara H; Fukuda S; Tanaka S
    Auris Nasus Larynx; 2017 Aug; 44(4):447-457. PubMed ID: 27595504
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of Oct3/4 and Nanog in the head and neck squamous carcinoma cells and its clinical implications for delayed neck metastasis in stage I/II oral tongue squamous cell carcinoma.
    Habu N; Imanishi Y; Kameyama K; Shimoda M; Tokumaru Y; Sakamoto K; Fujii R; Shigetomi S; Otsuka K; Sato Y; Watanabe Y; Ozawa H; Tomita T; Fujii M; Ogawa K
    BMC Cancer; 2015 Oct; 15():730. PubMed ID: 26483189
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Functional expression of the angiotensin II type 1 receptor in human ovarian carcinoma cells and its blockade therapy resulting in suppression of tumor invasion, angiogenesis, and peritoneal dissemination.
    Suganuma T; Ino K; Shibata K; Kajiyama H; Nagasaka T; Mizutani S; Kikkawa F
    Clin Cancer Res; 2005 Apr; 11(7):2686-94. PubMed ID: 15814650
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Involvement of the Wnt/β-Catenin signaling pathway in the heterogenous nuclear ribonucleoprotein K-driven inhibition of proliferation and migration in head and neck squamous cell carcinoma.
    Liu H; Chen X; Yang X; Li M; Zhang W; Zhang G; Zhan X; Cao L; Li W; Huang Z; Gao R
    Oncol Lett; 2020 Dec; 20(6):394. PubMed ID: 33193854
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pescadillo ribosomal biogenesis factor 1 reduction suppresses tumour growth and renders chemosensitivity of head and neck squamous cell carcinoma.
    Li D; Yao C; Ding Z; Liu P; Chen X; Liu W; Yi F; Jiang C; Li H; Liu Y; Wu J
    Cancer Med; 2023 Mar; 12(5):5703-5717. PubMed ID: 36217758
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of CCT3 as a prognostic factor and correlates with cell survival and invasion of head and neck squamous cell carcinoma.
    Wang Y; Liu P; Zhang Z; Wang J; Cheng Z; Fan C
    Biosci Rep; 2021 Oct; 41(10):. PubMed ID: 34505628
    [TBL] [Abstract][Full Text] [Related]  

  • 27. UBE2C promotes the progression of head and neck squamous cell carcinoma.
    Jin Z; Zhao X; Cui L; Xu X; Zhao Y; Younai F; Messadi D; Hu S
    Biochem Biophys Res Commun; 2020 Mar; 523(2):389-397. PubMed ID: 31870550
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tristetraprolin regulates interleukin-6, which is correlated with tumor progression in patients with head and neck squamous cell carcinoma.
    Van Tubergen E; Vander Broek R; Lee J; Wolf G; Carey T; Bradford C; Prince M; Kirkwood KL; D'Silva NJ
    Cancer; 2011 Jun; 117(12):2677-89. PubMed ID: 21656745
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ALIX promotes cell migration and invasion of head and neck squamous cell carcinoma by regulating the expression of MMP9, MMP14, VEGF-C.
    Xie QH; Wang WM; Yang JG; Xia HF; Xiao BL; Chen GH; Huang J; Li RF; Chen G
    Arch Oral Biol; 2023 Jul; 151():105696. PubMed ID: 37086494
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aberrant overexpression of transcription factor Forkhead box D1 predicts poor prognosis and promotes cancer progression in HNSCC.
    Li J; Yan T; Wu X; Ke X; Li X; Zhu Y; Yang J; Li Z
    BMC Cancer; 2021 Nov; 21(1):1205. PubMed ID: 34772357
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Glucose transporter 4 promotes head and neck squamous cell carcinoma metastasis through the TRIM24-DDX58 axis.
    Chang YC; Chi LH; Chang WM; Su CY; Lin YF; Chen CL; Chen MH; Chang PM; Wu AT; Hsiao M
    J Hematol Oncol; 2017 Jan; 10(1):11. PubMed ID: 28061796
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SESN1, negatively regulated by miR-377-3p, suppresses invasive growth of head and neck squamous cell carcinoma by interaction with SMAD3.
    Zhang C; Ren L; Zhang H; Yang S; Deng M; He L; Cao R; Zhao C; Xia J
    Hum Cell; 2022 Jul; 35(4):1100-1113. PubMed ID: 35622213
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification and validation of a poor clinical outcome subtype of primary prostate cancer with Midkine abundance.
    Zhou Q; Yang C; Mou Z; Wu S; Dai X; Chen X; Ou Y; Zhang L; Sha J; Jiang H
    Cancer Sci; 2022 Nov; 113(11):3698-3709. PubMed ID: 36018546
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Survival-related indicators ALOX12B and SPRR1A are associated with DNA damage repair and tumor microenvironment status in HPV 16-negative head and neck squamous cell carcinoma patients.
    Li J; Tang LL; Ma J
    BMC Cancer; 2022 Jun; 22(1):714. PubMed ID: 35768785
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long non-coding RNA LINC01296 acts as a migration and invasion promoter in head and neck squamous cell carcinoma and predicts poor prognosis.
    Wu J; Chen H; Li J; Li X; Cao J; Qi M
    Bioengineered; 2021 Dec; 12(1):5607-5619. PubMed ID: 34515611
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel intronic circular RNA, circGNG7, inhibits head and neck squamous cell carcinoma progression by blocking the phosphorylation of heat shock protein 27 at Ser78 and Ser82.
    Ju H; Hu Z; Wei D; Huang J; Zhang X; Rui M; Li Z; Zhang X; Hu J; Guo W; Ren G
    Cancer Commun (Lond); 2021 Nov; 41(11):1152-1172. PubMed ID: 34498800
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Midkine expression in high grade gliomas: Correlation of this novel marker with proliferation and survival in human gliomas.
    Cheng YP; Lin C; Lin PY; Cheng CY; Ma HI; Chen CM; Hueng DY
    Surg Neurol Int; 2014; 5():78. PubMed ID: 24949221
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Study on the Correlations of the miR-31 Expression with the Pathogenesis and Prognosis of Head and Neck Squamous Cell Carcinoma.
    Qiang H; Zhan X; Wang W; Cheng Z; Ma S; Jiang C
    Cancer Biother Radiopharm; 2019 Apr; 34(3):189-195. PubMed ID: 30628842
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Angiotensin II type 1 receptor expression in ovarian cancer and its correlation with tumour angiogenesis and patient survival.
    Ino K; Shibata K; Kajiyama H; Yamamoto E; Nagasaka T; Nawa A; Nomura S; Kikkawa F
    Br J Cancer; 2006 Feb; 94(4):552-60. PubMed ID: 16434990
    [TBL] [Abstract][Full Text] [Related]  

  • 40. FUT6 inhibits the proliferation, migration, invasion, and EGF-induced EMT of head and neck squamous cell carcinoma (HNSCC) by regulating EGFR/ERK/STAT signaling pathway.
    Wang Q; Liao C; Tan Z; Li X; Guan X; Li H; Tian Z; Liu J; An J
    Cancer Gene Ther; 2023 Jan; 30(1):182-191. PubMed ID: 36151332
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.